The Editor’s choice in the most recent edition of the EJHP is a report of a European consensus conference on guidelines for the practical stability studies of anticancer drugs.

The conference was held in France in May 2010, under the auspices of the French Society of Oncology Pharmacy (SFPO), to propose adapted rules on stability of anticancer drugs in practical situations and guidelines for performing corresponding stability studies.

The conference looked at such issues as acceptance limits of degradation for individual drugs and the use of validated stability indicating methods. The conference also focused on the need to perform more studies on the stability of biotherapies, including a minimum of three complementary separating methods and careful evaluation of submicronic aggregates.

Report of conference here